United Kingdom · Growth startup
Funding summaryUpdated 26 Oct 2026
$525Mraised across 8 rounds since 2013, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Venrock Healthcare Capital PartnersLead
RA Capital Management
Sofinnova Partners
Forbion Capital Partners
PfizerReported by Ventureburn
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Reported by TechStartups
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
CellCentric filed 10 raises, $412M in all. Filings say how much was sold and to how many investors; they never name the investors.
From CellCentric's own website: 44 on the team.
And 26 more on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
RA Capital ManagementLForbion Capital PartnersVenrock Healthcare Capital PartnersLFidelitySofinnova PartnersPfizerHBM HealthcareAvego Bioscience Capital
BrightEdgeMissing a round, or an investor who was in one? Tell us.
These 3 firms list CellCentric as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
CellCentric's investors include RA Capital Management, Forbion Capital Partners, Venrock Healthcare Capital Partners, Fidelity and Sofinnova Partners, and 4 more on record. Venrock Healthcare Capital Partners led its latest round.
CellCentric has raised $525M across 8 rounds since 2013.
CellCentric's most recent round was a Growth of $220M in May 2026, led by Venrock Healthcare Capital Partners.
Its most recent round, $220M in May 2026, is also its largest on record.
CellCentric's first round on record, in May 2025, was backed by RA Capital Management, Forbion Capital Partners and Avego Bioscience Capital and 1 others.
CellCentric's latest named round is a Growth, in May 2026.
CellCentric is based in the United Kingdom.
RA Capital Management led the Series C in 2025; Venrock Healthcare Capital Partners led the Growth in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
